Virogenomics: a novel approach to antiviral drug discovery
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (12) , 621-627
- https://doi.org/10.1016/s1359-6446(01)01808-6
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cellsBlood, 2000
- Activation of heat-shock response by an adenovirus is essential for virus replicationNature, 2000
- The Impact of Genomics on Drug DiscoveryAnnual Review of Pharmacology and Toxicology, 2000
- Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole on HCMV DNA replication and permissive infectionAntiviral Research, 1999
- The emerging role of fusion inhibitors in HIV infection.Drugs in R&D, 1999
- Strategies for Antiviral Drug DiscoveryAntiviral Chemistry and Chemotherapy, 1998
- Backbone Cyclic Peptide, Which Mimics the Nuclear Localization Signal of Human Immunodeficiency Virus Type 1 Matrix Protein, Inhibits Nuclear Import and Virus Production in Nondividing CellsBiochemistry, 1998
- Inhibition of Cellular Cdk2 Activity Blocks Human Cytomegalovirus ReplicationVirology, 1997